Research Announcements

OnPAR to Provide Second Chance for Rejected NIH Proposals

The Online Partnership to Accelerate Research (OnPAR) was conceived to re-accelerate the biomedical research and development enterprise by seeking a larger return on NIH’s peer review investment on research proposals evaluated in the top 30% in each NIH Institute and Center.

The goal of OnPAR is to match quality biomedical research projects with priority areas of interest of private foundations, and pharmaceutical and biotech companies and/or other private biomedical research funders. OnPAR will eventually provide access to a global pipeline of research projects that can either supplement internal projects or provide innovative new ideas for future medical products.

OnPAR FAQs
Register for OnPAR

Leidos has worked with NIH Program Officers to inform applicant Principal Investigators that have scored well, but below the Institute/Center payline, about OnPAR. If an applicant scored in the top 30% and is not funded by NIH, he/she is welcome to submit an abstract for consideration. Qualified applicants are invited to register with OnPAR and participate in the submission and review process described below. It is not necessary to re-write an application. OnPAR will accept the NIH abstract that was submitted by the applicant, and if invited, his/her submitted NIH application and Summary Statement.

Leave a Reply

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.